FDA Import Refusal 8DS-0316389-8/31/1 — Janssen Inc.
The FDA refused shipment 8DS-0316389-8/31/1 from Janssen Inc. (Canada) on Sep 10, 2020. The refused product falls under Drugs and Biologics — DOXORUBICIN HYDROCHLORIDE (ANTITUMOR). Cited charge: 118 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 10, 2020
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 56HDK24 DOXORUBICIN HYDROCHLORIDE (ANTITUMOR)
- Charges
- 118